Cargando…

Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency

BACKGROUND: Clinical B(12) deficiency with hematological or neurological manifestations is rare. An unusual manifestation of B(12) deficiency is pseudo-thrombotic microangiopathy (TMA), which is characterized by hemolytic anemia, thrombocytopenia, and schistocytosis and only occurs in 2.5% of those...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrissey, Dylan, Sun, Yuheng, Koilpillai, Sarina, Kropf, Jacqueline, Carlan, Steve J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464104/
https://www.ncbi.nlm.nih.gov/pubmed/36097512
http://dx.doi.org/10.1155/2022/7306070
_version_ 1784787508831191040
author Morrissey, Dylan
Sun, Yuheng
Koilpillai, Sarina
Kropf, Jacqueline
Carlan, Steve J.
author_facet Morrissey, Dylan
Sun, Yuheng
Koilpillai, Sarina
Kropf, Jacqueline
Carlan, Steve J.
author_sort Morrissey, Dylan
collection PubMed
description BACKGROUND: Clinical B(12) deficiency with hematological or neurological manifestations is rare. An unusual manifestation of B(12) deficiency is pseudo-thrombotic microangiopathy (TMA), which is characterized by hemolytic anemia, thrombocytopenia, and schistocytosis and only occurs in 2.5% of those with B(12) deficiency. Pseudo-TMA is misdiagnosed as thrombotic thrombocytopenic purpura (TTP) in 40% of cases, resulting in misguided treatment including plasmapheresis. CASE: A 44-year-old Hispanic presented with 3 weeks of progressively worsening non-radiating chest pain, fatigue, and shortness of breath (SOB). Laboratory findings revealed severe pancytopenia and macrocytosis with a hemoglobin of 5.4 g/dL, mean corpuscular volume of 116.3 fL, and vitamin B(12) low at 149 pg/mL. She was diagnosed with pseudo-TMA and after starting 1000 micrograms of parenteral vitamin B(12) injections daily and discontinuing plasmapheresis and steroid administration, she improved. CONCLUSION: Failure to recognize pseudo-TMA often results in unnecessary treatment with plasmapheresis and delays appropriate treatment with vitamin B(12) supplementation. It is therefore extremely important to consider pseudo-TMA as a differential diagnosis in patients that present with hemolytic anemia, thrombocytopenia, and schistocytosis.
format Online
Article
Text
id pubmed-9464104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94641042022-09-11 Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency Morrissey, Dylan Sun, Yuheng Koilpillai, Sarina Kropf, Jacqueline Carlan, Steve J. Case Rep Med Case Report BACKGROUND: Clinical B(12) deficiency with hematological or neurological manifestations is rare. An unusual manifestation of B(12) deficiency is pseudo-thrombotic microangiopathy (TMA), which is characterized by hemolytic anemia, thrombocytopenia, and schistocytosis and only occurs in 2.5% of those with B(12) deficiency. Pseudo-TMA is misdiagnosed as thrombotic thrombocytopenic purpura (TTP) in 40% of cases, resulting in misguided treatment including plasmapheresis. CASE: A 44-year-old Hispanic presented with 3 weeks of progressively worsening non-radiating chest pain, fatigue, and shortness of breath (SOB). Laboratory findings revealed severe pancytopenia and macrocytosis with a hemoglobin of 5.4 g/dL, mean corpuscular volume of 116.3 fL, and vitamin B(12) low at 149 pg/mL. She was diagnosed with pseudo-TMA and after starting 1000 micrograms of parenteral vitamin B(12) injections daily and discontinuing plasmapheresis and steroid administration, she improved. CONCLUSION: Failure to recognize pseudo-TMA often results in unnecessary treatment with plasmapheresis and delays appropriate treatment with vitamin B(12) supplementation. It is therefore extremely important to consider pseudo-TMA as a differential diagnosis in patients that present with hemolytic anemia, thrombocytopenia, and schistocytosis. Hindawi 2022-09-03 /pmc/articles/PMC9464104/ /pubmed/36097512 http://dx.doi.org/10.1155/2022/7306070 Text en Copyright © 2022 Dylan Morrissey et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Morrissey, Dylan
Sun, Yuheng
Koilpillai, Sarina
Kropf, Jacqueline
Carlan, Steve J.
Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title_full Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title_fullStr Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title_full_unstemmed Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title_short Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
title_sort pseudo-thrombotic microangiopathy secondary to vitamin b12 deficiency
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464104/
https://www.ncbi.nlm.nih.gov/pubmed/36097512
http://dx.doi.org/10.1155/2022/7306070
work_keys_str_mv AT morrisseydylan pseudothromboticmicroangiopathysecondarytovitaminb12deficiency
AT sunyuheng pseudothromboticmicroangiopathysecondarytovitaminb12deficiency
AT koilpillaisarina pseudothromboticmicroangiopathysecondarytovitaminb12deficiency
AT kropfjacqueline pseudothromboticmicroangiopathysecondarytovitaminb12deficiency
AT carlanstevej pseudothromboticmicroangiopathysecondarytovitaminb12deficiency